-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse Xetra FrankfurtEURISIN US75886FAE79-
Regeneron Pharmaceuticals Inc.Börse NasdaqISIN US75886F1075 WKN: 881535Symbol REGN
-
Regeneron PharmaceuticalsBörse Xetra FrankfurtISIN US75886FAE79EURSymbol RGO
-
Regeneron PharmaceuticalsBörse Börse FrankfurtEURSymbol RGO
-
Regeneron PharmaceuticalsBörse Börse BerlinEURSymbol RGO
-
Regeneron PharmaceuticalsBörse Börse StuttgartEURSymbol RGO
-
Regeneron PharmaceuticalsBörse Börse MünchenEURSymbol RGO
-
REGENERON PHARMACEUTICALSBörse Quotrix System der Börse DüsseldorfEURSymbol RGO
-
REGENERON PHARMACEUTICALSBörse Börse DüsseldorfEURSymbol RGO
-
REGENERON PHARMACEUTICALSBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol RGO
-
REGENERON PHARMACEUTICALSBörse Gettex System der Börse MünchenEURSymbol RGO
-
Regeneron PharmaceuticalsBörse Börse Stuttgart
-
Regeneron PharmaceuticalsBörse NasdaqISIN US75886F1075 WKN: 881535USDSymbol REGN
-
Regeneron PharmaceuticalsBörse Bolsa Mexicana de Valore Mexiko-StadtMXNISIN US75886FAF45
-
Regeneron Pharmaceuticals, Inc.Börse London Stock Exchange
-
Regeneron Pharmaceuticals, Inc.Börse BVMF
-
Regeneron Pharmaceuticals, Inc.Börse Bolsa Mexicana de Valore Mexiko-Stadt
-
ISIN US75886FAE79
Symbol RGO
Währung
EUR
Börse
Xetra Frankfurt Zeitzone: Europe/Berlin
Firmenname
Regeneron Pharmaceuticals, Inc
Marktkapitalisierung
54.389.120.217 (+- 6%)
Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:
54.622.801.920 oder 57.888.000.000 oder 50.656.558.731
Mitarbeiter
10.207 (+- 19%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
8.314 oder 12.099 Mitarbeiter
Anzahl Aktien
104.857.294
KGV
19.08 (+- 2%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
18.76 oder 19.4
EBITDA 3.348.999.936
PEGRatio 0.9353
Buchwert 96.011
Aktionärsstruktur der Regeneron Pharmaceuticals, Inc
Portrait der Regeneron Pharmaceuticals Aktie
Das Unternehmen Regeneron Pharmaceuticals, Inc aus USA beschäftigt 10.207 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie & Pharmazeutika, Biotechnologie, Pharma tätig.
Das Unternehmen Regeneron Pharmaceuticals, Inc ist in mehr als 79 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter VanEck Vectors Biotech ETF gewichtet Regeneron Pharmaceuticals mit 5,83% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Regeneron Pharmaceuticals Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen Regeneron Pharmaceuticals, Inc am höchsten gewichtet ist Insgesamt in 79 ETFs enthalten
Dir gefallen die Informationen zu Regeneron Pharmaceuticals?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Regeneron Pharmaceuticals?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Regeneron Pharmaceuticals?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Regeneron Pharmaceuticals?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
184 News & Informationen zur Regeneron Pharmaceuticals Aktie
Intellia Therapeutics Names James Basta, J.D., As Executive Vice President, General Counsel And Corporate Secretary
CAMBRIDGE, Mass., June 24, 2021 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ: NTLA), a leading genome editing company focused on developing curative
Can You Count on 23andMe Stock?
This innovative consumer genetic testing company is more than meets the eye.
Regeneron Pharmaceuticals : to Participate in Guggenheim Biopharma Strategy Series
TARRYTOWN, N.Y., June 22, 2021 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. is scheduled to participate in a virtual fireside chat at the Guggenheim Biopharma Strategy Series –… | June 22, 2021
Regeneron Pharmaceuticals, Inc. (REGN) Management Presents at BMO Biopharma Day Conference (Transcript)
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) BMO Biopharma Day Conference June 22, 2021 08:00 AM ET Company Participants Justin Holko – VP of IR Neil Stahl – EVP of Research &…
Merck, Partner Halt Covid-19 Treatment Trial for Hospitalized Patients
The company and a partner will move forward with a separate study testing their oral antiviral drug in treating outpatients who are at high risk of complications.
Bronte Capital Management Pty Ltd. Buys Alphabet Inc, Regeneron Pharmaceuticals Inc, Altria Group Inc, Sells Interactive Brokers Group Inc, Visa Inc, Alphabet Inc
Bronte Capital Management Pty Ltd. Buys Alphabet Inc, Regeneron Pharmaceuticals Inc, Altria Group Inc, Sells Interactive Brokers Group Inc, Visa Inc, Alphabet Inc, Stocks: GOOGL,REGN,MO,, release date:Apr 13, 2021
COVID-19 cases keep surging in some U.S. states, and Michigan governor continues plea for more vaccines as shots in arms hits daily record
The U.S. is facing another surge in new COVID-19 cases in some states, led by Michigan, but the White House has spurned Michigan Gov. Gretchen Whitmer…
5 Blue-Chip Biotech Stocks to Buy in 2021
Discover the best biotech stocks to buy for both long-term investors and short-term traders as the industry continues to grow.
HighPoint Advisor Group LLC Buys Sherwin-Williams Co, Applied Materials Inc, News Corp, Sells Novavax Inc, Lululemon Athletica Inc, T-Mobile US Inc
HighPoint Advisor Group LLC Buys Sherwin-Williams Co, Applied Materials Inc, News Corp, Sells Novavax Inc, Lululemon Athletica Inc, T-Mobile US Inc, Stocks: SHW,AMAT,NOW,VIAC,LHX,PLTR,MGA,NWSA,AMKR,EWBC,SHAK, release date:Apr 12, 2021
Here’s Why Biotech Investors Should Buy Regeneron Pharmaceuticals Now By StockNews
Here’s Why Biotech Investors Should Buy Regeneron Pharmaceuticals Now
Nvidia and Adobe Lead Off My 30-30 Club
Nvidia and Adobe Lead Off My 30-30 Club, Stocks: NVDA,ADBE,INTU,LRCX,ZTS,NSP,CTXS,BJ,TPX,MED,BIO,FT, release date:Apr 12, 2021
Why the Mutated Coronavirus Variants Are So Worrisome
Viruses mutate all the time, including the novel coronavirus that’s caused the global Covid-19 pandemic. Most of the changes have no apparent effect. But recent variants that have emerged in the U.K., South Africa and Brazil are causing particular concern.
Taking A Breather for Now
The stock market rode into the weekend on a high note. In fact, it was the highest of notes for the Dow Jones Industrial Average and S&P 500, which closed at record highs.
Regeneron drug prevents symptomatic Covid-19 by 81%
Regeneron 'says it will ask federal health regulators to clear use among people who haven’t been vaccinated', reports The Wall Street Journal
Covid-19 Drug Prevents Symptomatic Disease in Study, Regeneron Says
The antibody drug reduced the risk of developing symptomatic Covid-19 infection by 81% compared with a placebo in people living with someone infected by the new coronavirus, a study found.
4 Undervalued Stocks To Watch For In April
EBay Inc (NASDAQ:EBAY), SunPower Corporation (NASDAQ:SPWR), Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Tupperware Brands …
U.S. Officials Plead for More Use of Languishing Antibody Drugs
(Bloomberg) —
U.S. health officials are pleading for more use of Covid-19 antibody therapies from Eli Lilly and Co. and Regeneron Pharmaceuticals Inc. that have been plagued by logistical issues, lack of efficacy data and insufficient reimbursement.
U.S. Officials Plead for More Use of Languishing Antibody Drugs
Regeneron Pharmaceuticals (REGN) Presents At 39th Annual JPMorgan Virtual Healthcare Conference – Slideshow (NASDAQ:REGN)
Retinal Biologics Market to hit US $18.3 billion by 2028 – Global Insights on Trends, Growth Drivers, Investment Plans, Expansion Analysis, COVID-18 Impact, Key Players and Future Opportunities: Adroi
Dallas, Texas, Jan. 14, 2021 (GLOBE NEWSWIRE) — The global retinal biologics market is projected to grow at a CAGR of 6.5%. Increasing prevalence of …
Why Regeneron, Jaguar Health And Seneca Are Moving Today
Regeneron Pharmaceuticals (NASDAQ: REGN) shares are trading higher after the company announced an additional U.S. order to purchase 1.25 million doses of …
U.S. sees record one-day death toll and experts worry new variant may make activities like plane travel more risky
The U.S. set another grim milestone in the coronavirus pandemic on Tuesday, when more than 4,400 COVID-19 patients died, the most in a single day since the…
5 Penny Stocks to Watch If Biotech Stocks Are Your Focus in January 2021
What to watch today: Stocks set for modest drop
U.S. stock futures fell Wednesday, a day after Wall Street resumed its 2021 upswing with modest gains.
Stocks making the biggest moves in the premarket: Urban Outfitters, Target, KB Home & more
The stocks making the biggest moves in premarket trading include Urban Outfitters, Target, KB Home, and more.
Regeneron To Supply US With Another 1.25M COVID-19 Treatment Doses
Biotech company Regeneron Pharmaceuticals Inc (NASDAQ: REGN) announced the signing of a $2.625 billion supply agreement with the U.S. government for its …
Regeneron says U.S. government to buy 1.25 million doses of its COVID-19 treatment
Regeneron Pharmaceuticals Inc. undefined said late Tuesday that the U.S. government has agreed to buy an additional 1.25 million doses of the company's…
Regeneron Pharmaceuticals : U.S. government to buy 1.25 mln additional doses of Regeneron's COVID-19 antibody cocktail
The U.S. government will buy 1.25 million
additional doses of Regeneron Pharmaceuticals Inc's
COVID-19 antibody cocktail to be used in non-hospitalized
COVID-19 patients, the drugmaker said on… | January 12, 2021
Regeneron Pharmaceuticals : Announces U.S. Government Agreement to Purchase Additional COVID-19 Antibody Cocktail Doses
TARRYTOWN, N.Y., Jan. 12, 2021 /PRNewswire/ –?
New agreement covers 1.25 million additional doses of the casirivimab and imdevimab antibody cocktail, bringing total potential U.S. supply to… | January 12, 2021
Regeneron Announces U.S. Government Agreement to Purchase Additional COVID-19 Antibody Cocktail Doses
TARRYTOWN, N.Y., Jan. 12, 2021 /PRNewswire/ —
New agreement covers 1.25 million additional doses of the casirivimab and imdevimab antibody cocktail, …
Dr. Fauci warns Covid variant found in South Africa could pose threat to antibody drugs
A more infectious coronavirus strain first identified in South Africa is “disturbing” and could pose a threat to Covid antibody drugs, Dr. Anthony Fauci said.
Covid strain found in South Africa ‘could evade’ Eli Lilly's antibody drug, CEO warns
“The South African variant … is the one of concern. It has more dramatic mutations to that spike protein,” Eli Lilly CEO Dave Ricks said.
GSK, Vir to test antibody for Covid-19 treatment
Trial will begin in the first quarter of 2021
Bill Nygren's Oakmark Fund 4th-Quarter Shareholder Commentary
Bill Nygren's Oakmark Fund 4th-Quarter Shareholder Commentary, Stocks: FISV,KKR,ALLY,SCHW,SPGI,REGN,NFLX,FB,FCAU,WFC,, Bill Nygren, release date:Jan 11, 2021
Get Ready For Health Care Stocks to Go Wild. How to Play Them.
Politics is the hot story of January, but health care might be the hot trade.
GOLDMAN SACHS: Buy these 37 stocks that could earn you the strongest returns without taking on big risks in 2021 as the recovery and vaccine distribution get underway
Why Aren’t Doctors Prescribing Eli Lilly’s and Regeneron’s COVID-19 Treatments?
Finding eligible patients and treating them is harder than it sounds.
Covid-19 Vaccine’s Slow Rollout Could Portend More Problems
By Jared S. Hopkins and Arian Campo-Flores
Three weeks into the most ambitious vaccination campaign in modern U.S. history, far fewer people are being protected against Covid-19 as the process… | January 1, 2021
Covid-19 Vaccine’s Slow Rollout Could Portend More Problems
Far fewer people are being protected against Covid-19 as the process moves slower than officials had projected and has been beset by confusion and disorganization in many states.
11.06.2020 ANALYSE-FLASH: RBC belässt Regeneron Pharmaceuticals auf 'Sector Perform' Zum Artikel